Suscripción a Biblioteca: Guest
Critical Reviews™ in Biomedical Engineering

Publicado 6 números por año

ISSN Imprimir: 0278-940X

ISSN En Línea: 1943-619X

SJR: 0.262 SNIP: 0.372 CiteScore™:: 2.2 H-Index: 56

Indexed in

An Experimental Platform for Characterizing Cancer Biomarkers with Capabilities in Noninvasive and Continuous Screening

Volumen 47, Edición 3, 2019, pp. 217-234
DOI: 10.1615/CritRevBiomedEng.2019026426
Get accessGet access

SINOPSIS

Early detection is crucial to the proper and effective treatment of two metastatic cancers, prostate cancer and small cell lung cancer. Currently, preventative screenings for these conditions are restricted to high-risk populations and extremely expensive. The discovery of clinically indicative biomarkers has been revolutionary in advancing screening and diagnostic capabilities. Prostate-specific antigen (PSA), an extracellular secreted protein of the prostate gland, and neuron-specific enolase (NSE), an enzyme of neuronal origin, have reported reputable specificity for prostate cancer and small cell lung cancer (SCLC). Current efforts are underway to develop a rapid, label-free means of measuring both PSA and NSE levels in a clinical environment for early screening applications of highly metastatic cancers. Electrochemical impedance spectroscopy (EIS) and impedance time (Z-t) are rapid, sensitive electrochemical techniques previously validated in the detection of several clinically relevant biomarkers, including cardiovascular disease and diabetes mellitus. Herein, we determine the optimal frequencies of PSA (81.38 Hz) and NSE (14.36 Hz) using EIS that are robust across analytical platforms and in the presence of potentially interfering species. The reported empirical evidence supports the prevalence of electrostatic interactions in electrochemical systems and provides alternative theoretical support of previous findings. Finally, Z-t was implemented for its utility in continuous monitoring applications and to lay the foundation for future improvements to continuous sensor platforms.

CITADO POR
  1. Pauliukaite Rasa, Voitechovič Edita, Multisensor Systems and Arrays for Medical Applications Employing Naturally-Occurring Compounds and Materials, Sensors, 20, 12, 2020. Crossref

  2. Strong Madison E., Richards Jeffrey R., Torres Manuel, Beck Connor M., La Belle Jeffrey T., Faradaic electrochemical impedance spectroscopy for enhanced analyte detection in diagnostics, Biosensors and Bioelectronics, 177, 2021. Crossref

  3. Borumand Mehrasa Rahimi, Babaloii Fatemeh, Mirmotahari Seyedeh Azin, Maghsoudi Armin Salek, Torabi Raheleh, Mojtahedzadeh Mojtaba, Norouzi Parviz, Rad-Malekshahi Mazda, Javar Hamid Akbari, Hassani Shokoufeh, Recent trends and innovations in biosensors development for biomarkers towards monitoring traumatic brain injury, Biosensors and Bioelectronics: X, 12, 2022. Crossref

745 Vistas de artículos 25 Descargas de artículos Métrica
745 PUNTOS DE VISTA 25 DESCARGAS 3 Crossref CITAS Google
Scholar
CITAS

Artículos con contenido similar:

Electrochemical Detection of Fertility Hormones Critical Reviews™ in Biomedical Engineering, Vol.47, 2019, issue 3
Victoria Smith, Jared Johns, Sandhya Santhanaraman, Mackenzie M. Honikel, Stephanie Maxwell, Jeffrey La Belle, Mukund Khanwalker
Inhibition of Hepatitis B Virus with the Help of CRISPR/Cas9 Technology Critical Reviews™ in Eukaryotic Gene Expression, Vol.30, 2020, issue 3
Akhtar Rasul, Muhammad Imran Qadir, Muhammad Shahid Iqbal, Muhammad Sajid Hamid Akash, Bilal Ahmed, Sadaf Noor
Facilitating Earlier Diagnosis of Cardiovascular Disease through Point-of-Care Biosensors: A Review Critical Reviews™ in Biomedical Engineering, Vol.46, 2018, issue 1
David Probst, Mackenzie M. Honikel, Jeffrey La Belle, Chi-En Lin
CRISPR/Cas9: A Molecular Tool for Ovarian Cancer Management beyond Gene Editing Critical Reviews™ in Oncogenesis, Vol.27, 2022, issue 4
Madhuri Radadiya, Amit Sonagra, Ragini D. Singh, Deepak Parchwani, Gaurav Sharma, Sagar Dholariya, Digishaben Patel
Development and Application of Tissue Microarrays for Biomarker Studies Onco Therapeutics, Vol.2, 2011, issue 2
Linda Shevlin, Lee Goodglick, Maoyong Fu, Yahya Elshimali, Samson Schatz, David Chia, Ai Li, Madhuri Wadehra, Steve Horvath, Nam K. Yoon, George Chang, Erin Maresh, Lily Zhang, Mohammad Alavi, Angela Presson, Lora Bagryanova, Longsheng Hong, Vei H. Mah
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain